Skip to main content
Erschienen in: Comparative Clinical Pathology 6/2019

06.08.2019 | Brief Communication

Clinical management of cutaneous hemangiosarcoma in canines: a review of five cases

verfasst von: Khan Sharun, Mohammed Arif Basha, Mudasir Ahmad Shah, K. Kumar, Pawan Kumar, S. Shivaraju, A. M. Pawde, Amarpal

Erschienen in: Comparative Clinical Pathology | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Hemangiosarcoma is a type of malignant vascular tumour that commonly affects the canines and has a very poor prognosis. Five dogs affected with cutaneous hemangiosarcoma were presented to Referral Veterinary Polyclinic, Indian Veterinary Research Institute, Izatnagar, over a 6-month period. All of the cases were subjected to thoracic radiography and intra-abdominal ultrasonography to rule out metastasis. The tumour mass was surgically excised in all the five animals. The cases were diagnosed as hemangiosarcoma on the basis of histopathology and immunohistochemistry. Two of the animals received chemotherapy using either vincristine or doxorubicin after surgical excision. The post-operative survival period was found to be slightly higher in the cases that received combined surgical excision and chemotherapy. The main aim of managing such cases should be to prolong the life of the animal by combining various treatment modalities like surgical excision, chemotherapy, immunotherapy and radiation therapy. This paper concludes that the combined use of surgical excision and chemotherapy can be superior to surgical excision alone in prolonging the life of dogs suffering from a cutaneous form of hemangiosarcoma.
Literatur
Zurück zum Zitat Batschinski K, Nobre A, Vargas-Mendez E, Tedardi MV, Cirillo J, Cestari G, Dagli MLZ (2018) Canine visceral hemangiosarcoma treated with surgery alone or surgery and doxorubicin: 37 cases (2005-2014). Can Vet J 59(9):967–972PubMedPubMedCentral Batschinski K, Nobre A, Vargas-Mendez E, Tedardi MV, Cirillo J, Cestari G, Dagli MLZ (2018) Canine visceral hemangiosarcoma treated with surgery alone or surgery and doxorubicin: 37 cases (2005-2014). Can Vet J 59(9):967–972PubMedPubMedCentral
Zurück zum Zitat Bravo R, Frank R, Blundell PA, Macdonald-Bravo H (1987) Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature 326:515–517CrossRef Bravo R, Frank R, Blundell PA, Macdonald-Bravo H (1987) Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature 326:515–517CrossRef
Zurück zum Zitat Brown NO, Patnaik AK, MacEwen EG (1985) Canine hemangiosarcoma: retrospective analysis of 104 cases. J Am Vet Med Assoc 186(1):56–58PubMed Brown NO, Patnaik AK, MacEwen EG (1985) Canine hemangiosarcoma: retrospective analysis of 104 cases. J Am Vet Med Assoc 186(1):56–58PubMed
Zurück zum Zitat Clifford CA, Mackin AJ, Henry CJ (2000) Treatment of canine hemangiosarcoma: 2000 and beyond. J Vet Intern Med 14(5):479–485CrossRef Clifford CA, Mackin AJ, Henry CJ (2000) Treatment of canine hemangiosarcoma: 2000 and beyond. J Vet Intern Med 14(5):479–485CrossRef
Zurück zum Zitat Dervisis NG, Dominguez PA, Newman RG, Cadile CD, Kitchell BE (2011) Treatment with DAV for advanced-stage hemangiosarcoma in dogs. J Am Anim Hosp Assoc 47(3):170–178CrossRef Dervisis NG, Dominguez PA, Newman RG, Cadile CD, Kitchell BE (2011) Treatment with DAV for advanced-stage hemangiosarcoma in dogs. J Am Anim Hosp Assoc 47(3):170–178CrossRef
Zurück zum Zitat Fosmire SP, Dickerson EB, Scott AM, Bianco SR, Pettengill MJ, Meylemans H, Padilla M, Frazer-Abel AA, Akhtar N, Getzy DM, Wojcieszyn J (2004) Canine malignant hemangiosarcoma as a model of primitive angiogenic endothelium. Lab Investig 84(5):562–572CrossRef Fosmire SP, Dickerson EB, Scott AM, Bianco SR, Pettengill MJ, Meylemans H, Padilla M, Frazer-Abel AA, Akhtar N, Getzy DM, Wojcieszyn J (2004) Canine malignant hemangiosarcoma as a model of primitive angiogenic endothelium. Lab Investig 84(5):562–572CrossRef
Zurück zum Zitat Gorden BH, Kim JH, Sarver AL, Frantz AM, Breen M, Lindblad-Toh K, O’Brien TD, Sharkey LC, Modiano JF, Dickerson EB (2014) Identification of three molecular and functional subtypes in canine hemangiosarcoma through gene expression profiling and progenitor cell characterization. Am J Pathol 184(4):985–995CrossRef Gorden BH, Kim JH, Sarver AL, Frantz AM, Breen M, Lindblad-Toh K, O’Brien TD, Sharkey LC, Modiano JF, Dickerson EB (2014) Identification of three molecular and functional subtypes in canine hemangiosarcoma through gene expression profiling and progenitor cell characterization. Am J Pathol 184(4):985–995CrossRef
Zurück zum Zitat Karabağli G, Düzgün O, Yildar E, Erdoğan Ö, Gürel A (2011) A hemangiosarcoma case in a dog. İstanbul Üniversitesi Veteriner Fakültesi Dergisi 37(2):161–165 Karabağli G, Düzgün O, Yildar E, Erdoğan Ö, Gürel A (2011) A hemangiosarcoma case in a dog. İstanbul Üniversitesi Veteriner Fakültesi Dergisi 37(2):161–165
Zurück zum Zitat Kim JH, Graef A, Dickerson E, Modiano J (2015) Pathobiology of hemangiosarcoma in dogs: research advances and future perspectives. Vet Sci 2(4):388–405CrossRef Kim JH, Graef A, Dickerson E, Modiano J (2015) Pathobiology of hemangiosarcoma in dogs: research advances and future perspectives. Vet Sci 2(4):388–405CrossRef
Zurück zum Zitat Lamerato-Kozicki AR, Helm KM, Jubala CM, Cutter GC, Modiano JF (2006) Canine hemangiosarcoma originates from hematopoietic precursors with potential for endothelial differentiation. Exp Hematol 34(7):870–878CrossRef Lamerato-Kozicki AR, Helm KM, Jubala CM, Cutter GC, Modiano JF (2006) Canine hemangiosarcoma originates from hematopoietic precursors with potential for endothelial differentiation. Exp Hematol 34(7):870–878CrossRef
Zurück zum Zitat Nóbrega DF, Sehaber VF, Madureira R, Bracarense APFRL (2019) Canine cutaneous haemangiosarcoma: biomarkers and survival. J Comp Pathol 166:87–96CrossRef Nóbrega DF, Sehaber VF, Madureira R, Bracarense APFRL (2019) Canine cutaneous haemangiosarcoma: biomarkers and survival. J Comp Pathol 166:87–96CrossRef
Zurück zum Zitat Ogilvie GK, Powers BE, Mallinckrodt CH, Withrow SJ (1996) Surgery and doxorubicin in dogs with hemangiosarcoma. J Vet Intern Med 10(6):379–384CrossRef Ogilvie GK, Powers BE, Mallinckrodt CH, Withrow SJ (1996) Surgery and doxorubicin in dogs with hemangiosarcoma. J Vet Intern Med 10(6):379–384CrossRef
Zurück zum Zitat Schultheiss PC (2004) A retrospective study of visceral and nonvisceral hemangiosarcoma and hemangiomas in domestic animals. J Vet Diagn Investig 16(6):522–526CrossRef Schultheiss PC (2004) A retrospective study of visceral and nonvisceral hemangiosarcoma and hemangiomas in domestic animals. J Vet Diagn Investig 16(6):522–526CrossRef
Zurück zum Zitat Smetana K, Gyorkey F, Chan PK, Tan E, Busch H (1983) Proliferating cell nuclear antigen (PCNA) and human malignant tumor nucleolar antigens (HMTNA) in nucleoli of human hematological malignancies. Blut 46(3):133–141CrossRef Smetana K, Gyorkey F, Chan PK, Tan E, Busch H (1983) Proliferating cell nuclear antigen (PCNA) and human malignant tumor nucleolar antigens (HMTNA) in nucleoli of human hematological malignancies. Blut 46(3):133–141CrossRef
Zurück zum Zitat U’ren LW, Biller BJ, Elmslie RE, Thamm DH, Dow SW (2007) Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma. J Vet Intern Med 21(1):113–120CrossRef U’ren LW, Biller BJ, Elmslie RE, Thamm DH, Dow SW (2007) Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma. J Vet Intern Med 21(1):113–120CrossRef
Zurück zum Zitat Ward H, Fox LE, Calderwood-Mays MB, Hammer AS, Couto CG (1994) Cutaneous hemangiosarcoma in 25 dogs: a retrospective study. J Vet Intern Med 8(5):345–348CrossRef Ward H, Fox LE, Calderwood-Mays MB, Hammer AS, Couto CG (1994) Cutaneous hemangiosarcoma in 25 dogs: a retrospective study. J Vet Intern Med 8(5):345–348CrossRef
Zurück zum Zitat Weisse C, Soares N, Beal MW, Steffey MA, Drobatz KJ, Henry CJ (2005) Survival times in dogs with right atrial hemangiosarcoma treated by means of surgical resection with or without adjuvant chemotherapy: 23 cases (1986–2000). J Am Vet Med Assoc 226(4):575–579CrossRef Weisse C, Soares N, Beal MW, Steffey MA, Drobatz KJ, Henry CJ (2005) Survival times in dogs with right atrial hemangiosarcoma treated by means of surgical resection with or without adjuvant chemotherapy: 23 cases (1986–2000). J Am Vet Med Assoc 226(4):575–579CrossRef
Zurück zum Zitat Wendelburg KM, Price LL, Burgess KE, Lyons JA, Lew FH, Berg J (2015) Survival time of dogs with splenic hemangiosarcoma treated by splenectomy with or without adjuvant chemotherapy: 208 cases (2001–2012). J Am Vet Med Assoc 247(4):393–403CrossRef Wendelburg KM, Price LL, Burgess KE, Lyons JA, Lew FH, Berg J (2015) Survival time of dogs with splenic hemangiosarcoma treated by splenectomy with or without adjuvant chemotherapy: 208 cases (2001–2012). J Am Vet Med Assoc 247(4):393–403CrossRef
Zurück zum Zitat Wiley JL, Rook KA, Clifford CA, Gregor TP, Sorenmo KU (2010) Efficacy of doxorubicin-based chemotherapy for non-resectable canine subcutaneous haemangiosarcoma. Vet Comp Oncol 8(3):221–233PubMed Wiley JL, Rook KA, Clifford CA, Gregor TP, Sorenmo KU (2010) Efficacy of doxorubicin-based chemotherapy for non-resectable canine subcutaneous haemangiosarcoma. Vet Comp Oncol 8(3):221–233PubMed
Metadaten
Titel
Clinical management of cutaneous hemangiosarcoma in canines: a review of five cases
verfasst von
Khan Sharun
Mohammed Arif Basha
Mudasir Ahmad Shah
K. Kumar
Pawan Kumar
S. Shivaraju
A. M. Pawde
Amarpal
Publikationsdatum
06.08.2019
Verlag
Springer London
Erschienen in
Comparative Clinical Pathology / Ausgabe 6/2019
Print ISSN: 1618-5641
Elektronische ISSN: 1618-565X
DOI
https://doi.org/10.1007/s00580-019-03039-1

Weitere Artikel der Ausgabe 6/2019

Comparative Clinical Pathology 6/2019 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …